title: Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver disease.
abstract: Interleukin-1 beta (IL-1 beta) genetic polymorphisms and IL-1 receptor antagonist (IL1RN) variable number tandem repeat (VNTR) seem to be related with the occurrence of chronic diseases. This study aimed to verify whether IL-1 beta -511>C/T, -31>T/C, +3953>C/T and IL1RN VNTR were associated to the development of liver cirrhosis. Two hundred forty cirrhotic patients were involved in the study. A significant trend was detected, for increasing cirrhosis frequencies, grouping the patients as follows: females and males carrying neither the IL-1 beta (-511 -31) T-C/T-C or T-C/(T-T or C-C) diplotypes nor any IL1RN A2 allele (138/292), males carrying either the IL-1 beta T-C/T-C or T-C/(T-T or C-C) diplotypes or at least one IL1RN A2 allele (74/147) and males carrying either the IL-1 beta T-C/T-C or T-C/(T-T or C-C) diplotypes and at least one IL1RN A2 allele (28/37) (p < 0.01). IL-1 beta polymorphisms are associated with the occurrence of end stage liver disease. IL-1 beta inflammatory activity appears more pronounced in males.
authors.affiliation: Laboratory Medicine, University of Udine, Piazzale S. M. della Misericordia 1, 33100, Udine, Italy.
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Fontanini
authors.forename: Annarosa
authors.initials: A
authors.lastname: Cussigh
authors.forename: Carlo
authors.initials: C
authors.lastname: Fabris
authors.forename: Edmondo
authors.initials: E
authors.lastname: Falleti
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Toniutto
authors.forename: Davide
authors.initials: D
authors.lastname: Bitetto
authors.forename: Sara
authors.initials: S
authors.lastname: Cmet
authors.forename: Elisa
authors.initials: E
authors.lastname: Fumolo
authors.forename: Ezio
authors.initials: E
authors.lastname: Fornasiere
authors.forename: Sara
authors.initials: S
authors.lastname: Bignulin
authors.forename: David J
authors.initials: DJ
authors.lastname: Pinato
authors.forename: Rosalba
authors.initials: R
authors.lastname: Minisini
authors.forename: Mario
authors.initials: M
authors.lastname: Pirisi
mesh_terms: D000328:Adult; D000368:Aged; D000483:Alleles; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006239:Haplotypes / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000150:complications / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000150:complications / Q000235:genetics; D006720:Homozygote; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000235:genetics*; D053583:Interleukin-1beta / Q000235:genetics*; D007558:Italy / Q000453:epidemiology; D008103:Liver Cirrhosis / Q000453:epidemiology / Q000209:etiology / Q000235:genetics*; D008104:Liver Cirrhosis, Alcoholic / Q000453:epidemiology / Q000235:genetics; D017093:Liver Failure / Q000453:epidemiology / Q000209:etiology / Q000235:genetics* / Q000601:surgery; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D018598:Minisatellite Repeats; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic / Q000235:genetics*; D055815:Young Adult
chemical_list: C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D053583:Interleukin-1beta